Loss of SDHB protein expression has therefore been used for prognostication in human medicine; in one study, the relationship between the SDH genetic background and SDHB immunohistochemistry sensitivity and specificity in human pheochromocytomas was 94.23% [9]. Here, SDHB is linked to hereditary pheochromocytoma-paraganglioma.